These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18402503)

  • 1. Urinary retention associated with ziprasidone: a case report.
    Mago R; Chism LM; Pinninti NR; Certa K
    J Clin Psychiatry; 2008 Mar; 69(3):499-500. PubMed ID: 18402503
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary hesitancy and retention caused by ziprasidone.
    Xomalis D; Bozikas VP; Garyfallos G; Nikolaidis N; Giouzepas J; Fokas K
    Int Clin Psychopharmacol; 2006 Jan; 21(1):71-2. PubMed ID: 16317320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
    Chung AK; Chua SE
    J Clin Psychopharmacol; 2007 Oct; 27(5):517-9. PubMed ID: 17873690
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone induced symptomatic bradycardia: a case report.
    Menon V; Kattimani S; Ayyanar S
    Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
    [No Abstract]   [Full Text] [Related]  

  • 5. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 6. Ziprasidone and weight gain.
    Jaworowski S; Hauser S; Mergui J; Hirsch H
    Clin Neuropharmacol; 2004; 27(2):99-100. PubMed ID: 15252274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
    Yang SH; McNeely MJ
    Am J Psychiatry; 2002 Aug; 159(8):1435. PubMed ID: 12153844
    [No Abstract]   [Full Text] [Related]  

  • 8. A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder.
    Das P
    J Clin Psychopharmacol; 2016 Aug; 36(4):393-4. PubMed ID: 27281388
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics.
    Lu BY; Lundgren R; Escalona PR; Roberts BB
    J Clin Psychiatry; 2002 Dec; 63(12):1185-6. PubMed ID: 12530423
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of ziprasidone associated with acutely worsened diabetes mellitus.
    Honigberg MC; Bui MP; Coconcea C
    Psychosomatics; 2013; 54(3):304-5. PubMed ID: 23680062
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
    Brieger P
    J Clin Psychiatry; 2004 Jan; 65(1):132-5. PubMed ID: 14744182
    [No Abstract]   [Full Text] [Related]  

  • 14. Ziprasidone and migraine headache.
    Boeker T
    Am J Psychiatry; 2002 Aug; 159(8):1435-6. PubMed ID: 12153843
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):108-9. PubMed ID: 18305296
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    Montejo AL; Rico-Villademoros F;
    J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychic akathisia.
    Kaye NS
    J Clin Psychopharmacol; 2003 Apr; 23(2):206; discussion 206-7. PubMed ID: 12640224
    [No Abstract]   [Full Text] [Related]  

  • 18. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ziprasidone. A new second-generation antipsychotic agent].
    Lublin HK
    Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone augmentation of clozapine in 11 patients.
    Kaye NS
    J Clin Psychiatry; 2003 Feb; 64(2):215-6. PubMed ID: 12633133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.